| scholarly article | Q13442814 |
| P356 | DOI | 10.3389/FIMMU.2018.00490 |
| P8608 | Fatcat ID | release_w4522ukdcnclfl7fnyejrscp6q |
| P932 | PMC publication ID | 5857529 |
| P698 | PubMed publication ID | 29593734 |
| P50 | author | Hans Lassmann | Q35704729 |
| Martin R Larsen | Q54560239 | ||
| Maria L Elkjaer | Q59690447 | ||
| Zsolt Illes | Q87617327 | ||
| Trevor Owens | Q48159418 | ||
| P2093 | author name string | Miklos Palkovits | |
| Arkadiusz Nawrocki | |||
| Agnieszka Wlodarczyk | |||
| Ferenc Gallyas | |||
| Viktor Molnar | |||
| Eirikur Benedikz | |||
| Nellie A Martin | |||
| Justyna Okarmus | |||
| Asa F Svenningsen | |||
| Eva K Thygesen | |||
| Gabor T Szilagyi | |||
| P2860 | cites work | Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis | Q21135220 |
| MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood | Q21562182 | ||
| miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice | Q24595073 | ||
| Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 | ||
| NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses | Q24670080 | ||
| MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response | Q26830890 | ||
| Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis | Q27008133 | ||
| Circulating microRNAs as biomarkers for disease staging in multiple sclerosis | Q28287246 | ||
| Multiple sclerosis: lessons from molecular neuropathology | Q28304076 | ||
| Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? | Q29042454 | ||
| Treatment of HCV infection by targeting microRNA | Q29547712 | ||
| Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species | Q30616090 | ||
| MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. | Q30937357 | ||
| PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements | Q31145457 | ||
| Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE. | Q33735496 | ||
| Thymosin β4 up-regulation of microRNA-146a promotes oligodendrocyte differentiation and suppression of the Toll-like proinflammatory pathway | Q33888545 | ||
| Development of microRNA therapeutics is coming of age. | Q33991443 | ||
| Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks | Q34170906 | ||
| The membrane fusion enigma: SNAREs, Sec1/Munc18 proteins, and their accomplices--guilty as charged? | Q34305507 | ||
| MicroRNA-146a in autoimmunity and innate immune responses. | Q34318595 | ||
| Migration of oligodendrocyte progenitor cells is controlled by transforming growth factor β family proteins during corticogenesis | Q34451698 | ||
| Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis | Q34524908 | ||
| Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage | Q35028421 | ||
| Mitochondria-associated microRNAs in rat hippocampus following traumatic brain injury. | Q35137505 | ||
| MicroRNA-146a inhibits glioma development by targeting Notch1 | Q35192143 | ||
| Thymic Atrophy and Apoptosis of CD4+CD8+ Thymocytes in the Cuprizone Model of Multiple Sclerosis | Q35656408 | ||
| Microglial recruitment, activation, and proliferation in response to primary demyelination | Q35757235 | ||
| A novel method for the simultaneous enrichment, identification, and quantification of phosphopeptides and sialylated glycopeptides applied to a temporal profile of mouse brain development | Q36386936 | ||
| miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database | Q36434925 | ||
| Remyelinating Oligodendrocyte Precursor Cell miRNAs from the Sfmbt2 Cluster Promote Cell Cycle Arrest and Differentiation | Q36534383 | ||
| Differential microRNA expression in blood in multiple sclerosis. | Q50901331 | ||
| The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. | Q51113861 | ||
| Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation. | Q51736194 | ||
| Age-related common miRNA polymorphism associated with severe toxicity in lung cancer patients treated with platinum-based chemotherapy. | Q53668460 | ||
| Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis | Q59543684 | ||
| Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study | Q85217159 | ||
| First microRNA mimic enters clinic | Q87067042 | ||
| MicroRNAs as potential biomarkers for doxorubicin-induced cardiotoxicity | Q89096618 | ||
| Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors | Q36920474 | ||
| MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease | Q36934113 | ||
| miRNAs in mtDNA-less cell mitochondria | Q37164369 | ||
| Modulation of miR-146a/complement factor H-mediated inflammatory responses in a rat model of temporal lobe epilepsy | Q37529408 | ||
| Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned | Q37634375 | ||
| MitomiRs in human inflamm-aging: a hypothesis involving miR-181a, miR-34a and miR-146a | Q38194343 | ||
| MicroRNA-146a down-regulation correlates with neuroprotection and targets pro-apoptotic genes in cerebral ischemic injury in vitro | Q38756264 | ||
| Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology? | Q38778433 | ||
| Improving the Phosphoproteome Coverage for Limited Sample Amounts Using TiO2-SIMAC-HILIC (TiSH) Phosphopeptide Enrichment and Fractionation | Q38818391 | ||
| MiR-146a promotes remyelination in a cuprizone model of demyelinating injury | Q38941942 | ||
| Multiple sclerosis animal models: a clinical and histopathological perspective | Q38993743 | ||
| MicroRNA expression aberration in Chinese patients with relapsing remitting multiple sclerosis | Q39317289 | ||
| Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing | Q39388435 | ||
| MicroRNA-146a Promotes Oligodendrogenesis in Stroke. | Q40135764 | ||
| A functional polymorphism in the pre‑miR‑146a gene influences the prognosis of glioblastoma multiforme by interfering with the balance between Notch1 and Notch2. | Q41593816 | ||
| MHC class II exacerbates demyelination in vivo independently of T cells | Q42080688 | ||
| Induction of oligodendrocyte differentiation and in vitro myelination by inhibition of rho-associated kinase | Q42149118 | ||
| MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis | Q43562745 | ||
| MicroRNA-146a represses LRP2 translation and leads to cell apoptosis in Alzheimer's disease | Q43753603 | ||
| Cuprizone inhibits demyelinating leukomyelitis by reducing immune responses without virus exacerbation in an infectious model of multiple sclerosis | Q45359704 | ||
| Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination | Q45757461 | ||
| Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes. | Q48117008 | ||
| miR-219 attenuates demyelination in cuprizone-induced demyelinated mice by regulating monocarboxylate transporter 1. | Q48206696 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 490 | |
| P577 | publication date | 2018-03-12 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice. | |
| P478 | volume | 9 |
| Q90638165 | CD8 T-cell Recruitment Into the Central Nervous System of Cuprizone-Fed Mice: Relevance to Modeling the Etiology of Multiple Sclerosis |
| Q61805331 | Correlation Between Smoking and Passive Smoking with Multiple Sclerosis and the Underlying Molecular Mechanisms |
| Q92814401 | Differential Expression of miRNAs and Behavioral Change in the Cuprizone-Induced Demyelination Mouse Model |
| Q99711187 | Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis |
| Q92262692 | Effect of Fasudil on remyelination following cuprizone-induced demyelination |
| Q64079845 | Epstein-Barr Virus and miRNAs: Partners in Crime in the Pathogenesis of Multiple Sclerosis? |
| Q91775192 | Proteomic changes during experimental de- and remyelination in the corpus callosum |
Search more.